The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 07, 2006
Filed:
May. 27, 2003
Andrei W. Konradi, Burlingame, CA (US);
Christopher M. Semko, Fremont, CA (US);
Ying-zi Xu, Palo Alto, CA (US);
Frank Stappenbeck, San Francisco, CA (US);
Brian P. Stupi, Moss Beach, CA (US);
Jenifer L. Smith, Daly City, CA (US);
Michael A. Pleiss, Sunnyvale, CA (US);
Eugene D. Thorsett, Kirkland, WA (US);
Andrei W. Konradi, Burlingame, CA (US);
Christopher M. Semko, Fremont, CA (US);
Ying-zi Xu, Palo Alto, CA (US);
Frank Stappenbeck, San Francisco, CA (US);
Brian P. Stupi, Moss Beach, CA (US);
Jenifer L. Smith, Daly City, CA (US);
Michael A. Pleiss, Sunnyvale, CA (US);
Eugene D. Thorsett, Kirkland, WA (US);
Elan Pharmaceuticals, Inc., South San Francisco, CA (US);
Wyeth, Madison, NJ (US);
Abstract
Disclosed are compounds which bind αintegrins, where the αintegrin is preferably VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by αintegrins, where the αintegrin is preferably VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.